Literature DB >> 236355

Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.

Y A Sidky, R Auerbach.   

Abstract

A new and sensitive assay for the effect of intracutanous administration of immunocompentent lymphocytes into the skin of irradiated unimmunized mice is described. The assay, which we have termed lymphocyte-induced angiogenesis (LIA) involves enumeration of new vascular branches induced by the action of these competent cells. As is the case for the previously described normal lymphocyte transfer reaction, LIA is a manifestation of the graft-vs.-host reaction, as shown by experiments utilizing appropaiate genetic combinations. The reaction is dose-dependent, and within the dose range of 2 times 10 minus 5 -4 times 10-6 cells the mumber of vessels induced correlates with the mumber of immunocompetent cells injected. At these dose levels spleen, lumph node, and hydrocortisone-resistant thymocytes are effective; bone marrow and thymus cells are not. Spleen cells from nude mice are incapable of inducing LIA, while mitomycin-C and irradiated lymphocytes can initiate but not maintain the reaction. The relationship between lymphocyte-induced angiogenesis has been discussed as have the implications of these findings to delayed hypersensitivity, inflammation, and vascular pathology.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236355      PMCID: PMC2189785          DOI: 10.1084/jem.141.5.1084

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  IMMUNOLOGICAL REACTIONS PRODUCED BY THE LOCAL INJECTION OF ADULT FOWL LEUCOCYTES IN CHICKENS.

Authors:  N L WARNER
Journal:  Aust J Exp Biol Med Sci       Date:  1964-06

2.  Tissue transplantation: a new approach to the "typing" problem.

Authors:  L BRENT; P B MEDAWAR
Journal:  Br Med J       Date:  1963-08-03

3.  LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Science       Date:  1964-02-21       Impact factor: 47.728

4.  Graft versus host reactions. Their natural history, and applicability as tools of research.

Authors:  M SIMONSEN
Journal:  Prog Allergy       Date:  1962

5.  A study of the passive cellular transfer of local cutaneous hypersensitivity. 3. Transfer of hypersensitivity to sheep erythrocytes with different cell types.

Authors:  A A Blazkovec; L Hulliger; E Sorkin
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

6.  Studies on delayed cutaneous inflammatory reactions elicited by inoculation of homologous cells into hamsters' skins.

Authors:  H Ramseier; R E Billingham
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

7.  Liver infiltration in the graft-versus-host reaction.

Authors:  G O Bain; W Y Suen; D W Remington; E Pinno
Journal:  Transplantation       Date:  1969-07       Impact factor: 4.939

8.  The influence of a graft-versus-host reaction on the incidence of metastases after tumor transplantation.

Authors:  C Carnaud; O Markowicz; N Trainin
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

Review 9.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

10.  In vitro induction of the graft-versus-host reaction.

Authors:  R Auerbach; A Globerson
Journal:  Exp Cell Res       Date:  1966-04       Impact factor: 3.905

View more
  45 in total

1.  Graft-versus-host reaction: a pathogenetic principle for the development of drug allergy, autoimmunity, and malignant lymphoma in non-chimeric individuals. Hypothesis.

Authors:  E Gleichmann; H Gleichmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

2.  Every allograft needs a silver lining.

Authors:  Alan G Contreras; David M Briscoe
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFα serum levels.

Authors:  Tadeusz M Zielonka; Urszula Demkow; Dorota Michalowska-Mitczuk; Malgorzata Filewska; Beata Bialas; Katarzyna Zycinska; Michael H Obrowski; Jan Kus; Ewa Skopinska-Rozewska
Journal:  Lung       Date:  2011-05-21       Impact factor: 2.584

4.  Relationship between the hair growth cycle and the intensity of lymphocyte-induced angiogenesis in mouse skin.

Authors:  S Majewski; G Tokarski; S Moskalewski
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 5.  Chronic allograft rejection: a fresh look.

Authors:  Johannes Wedel; Sarah Bruneau; Nora Kochupurakkal; Leo Boneschansker; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

6.  A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.

Authors:  I J Polakowski; M K Lewis; V R Muthukkaruppan; B Erdman; L Kubai; R Auerbach
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  [Disease-specific renal failure in angioimmunoblastic lymphadenopathy - remission by high dose prednisolone. A case report (author's transl)].

Authors:  E Platzer; R von Roemeling; B Kaduk; U Meinl
Journal:  Klin Wochenschr       Date:  1981-05-15

8.  Endothelial proliferation in experimental granulomatous colitis. Autoradiography and immunohistochemistry studies.

Authors:  N Pooley; L Ghosh; J Blanchard; P Sharon
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Proinflammatory functions of vascular endothelial growth factor in alloimmunity.

Authors:  Marlies E J Reinders; Masayuki Sho; Atsushi Izawa; Ping Wang; Debabrata Mukhopadhyay; Kerith E Koss; Christopher S Geehan; Andrew D Luster; Mohamed H Sayegh; David M Briscoe
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse.

Authors:  S P Andrade; L B Vieira; Y S Bakhle; P J Piper
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.